Announcement

OFFICIAL ANNOUNCEMENT ON THE ACQUISITION OF LABDOM’S OPERATIONS AND BRANDS

I am proud to officially announce the successful acquisition of Lab Dom AVMM (ASIA) Sdn. Bhd’s (LABDOM) operations and LABDOM’s distinguished brands, namely MFIII of Switzerland, LAB RMS, Swiss Cell, etc. for all nutritional supplements, aesthetic skincare and Biomedical devices, by Geoffrey Allan Holdings Inc. (GAH). These brands will now be licensed and managed by GAH’s wholly-owned subsidiary Nexgen Biopharma Ltd. (NEXGEN) with NEXGEN’s research division acquiring the IPs, trademarks and know-how from LABDOM Suisse Inc. On another note, the therapeutic range of products has been acquired by SBI Ltd.

To elaborate further, NEXGEN has also absorbed skilled Lab Dom AVMM (ASIA) Sdn. Bhd’s employees via its wholly owned Malaysian subsidiary NXG Shared Services Sdn. Bhd. based in Kota Kinabalu, effective 1st March 2015. All operations for the above specified product range will be managed under the existing team, from the same location.

Also from 1st March 2015, I have effectively relinquished all roles pertaining to the ownership and day-to-day operations of LABDOM and will now serve as an Independent Consultant. This will also afford me more time to explore opportunities in advocating and educating the public on integrative biomedical therapies through speaking engagements and authorship of publications.

I would like to assure you that all prior arrangements will be honoured during the transition period of 3-months starting from today, after which new agreements will be required to formalize your new relationship with NEXGEN.

On behalf of LABDOM, I would like to take this opportunity to thank you for your continuous support throughout these years and wish you continued growth with NEXGEN in the future. For any further clarifications on this matter, please email public.relations@nxgsharedservices.com.

Thank you.

For and on behalf of LABDOM
Dato Sri Prof. Mike Chan

 

To contact NEXGEN, click here.

To contact SBI, click here.